Allspring Global Investments Holdings, LLC Viking Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 3,670 shares of VKTX stock, worth $198,657. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,670
Previous 58,236
93.7%
Holding current value
$198,657
Previous $4.78 Million
95.94%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$547 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$326 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$277 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$122 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$101 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.15B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...